The effect of the Happi Liver mobile health application on the reduction of non-alcoholic fatty liver disease

• Conditions: fatty liver; non-alcoholic fatty liver disease; 10019654; 10003018

• Registration Number: NL-OMON52163
• Lead Sponsor: niversiteit Maastricht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 200

Inclusion Criteria

• Aged 18 years or older
• Diagnosed with NAFLD by CAPTM (>215 dB/m) as measured by the FibroScan®
device and VCTE <=7.2 kPa for the XL probe or <=7.9 kPa for the M-probe
• Able to give informed consent in Dutch
• Able to understand the information sheet and willing to comply with the study
protocol
• For the mobile app: a smartphone with a software version of at least iOS 13
or Android 7.0 Nougat

Exclusion Criteria

• Not proficient in the Dutch language
• Already in a weight-loss/management project included (e.g., weight watchers,
dietitian guidance).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Main study parameter/endpoint: a *5% reduction in weight measured in kg. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary study parameters/endpoints:<br /><br>1) Reduction of NAFLD (as measured by the FibroScan®).<br /><br>2) Acceptability and satisfaction of the Happi liver mobile application.<br /><br>3) An increase in knowledge concerning NAFLD.<br /><br>4) Quality of life improvement.</p><br>